By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Time for FDA to Hire Some Pharma Marketers?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Time for FDA to Hire Some Pharma Marketers?
BusinessPublic Health

Time for FDA to Hire Some Pharma Marketers?

DavidEWilliams
DavidEWilliams
Share
2 Min Read
SHARE

Turns out the Food and Drug Administration doesn’t achieve the impact it’s looking for in communications with physicians. That finding is drawn from a new paper that evaluates the impact of FDA warning labels and public health advisories over the past 20 years.

Some disappointing examples are noted:

Turns out the Food and Drug Administration doesn’t achieve the impact it’s looking for in communications with physicians. That finding is drawn from a new paper that evaluates the impact of FDA warning labels and public health advisories over the past 20 years.

Some disappointing examples are noted:

More Read

Clinical Pathways
Standardizing Patient Care with Clinical Pathways
Eeny Meeny Miney Money: Understanding Fee-for-Service Alternatives
Hospitals and Social Media: Are You Engaging the Right Audience?
Healthcare Companies Are Now Technology Companies?
More Sign Posts on the Road to Connected Health Adoption
  • FDA recommended diabetes monitoring for patients taking atypical antipsychotics, but testing did not increase
  • Warnings of drug/drug interaction weren’t heeded –at least for 18 months
  • When FDA warned about prescribing drugs in certain populations (e.g., atypical antipsychotics for dementia) there was an across the board reduction in prescribing
As I read the article, it occurred to me that FDA could learn best practices from big pharma about communicating with physicians and maybe should bring some onboard to help. With all the layoffs in pharma that should definitely be doable.
But the article stole my thunder, quoting a physician saying the same thing:
“The agency might learn a thing or two from the pharmaceutical firms that it regulates with respect to risk communication,” [Dr. Alexander from U Chicago] said. “They should be using principles of market segmentation to identify high-volume prescribers and then disseminating or conducting messaging of drug risks to those specific physicians.”


TAGGED:FDApharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Are We Picking on VA Hospitals Too Much?

June 8, 2014

Some Healthcare News and Views

December 19, 2014
Protected Health Information
BusinessMedical RecordsPolicy & Law

Protected Health Information Security: You Should Be Worried

September 23, 2014

Is Patient Engagement Changing Traditional HealthCare Marketing?

September 10, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?